Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.01.08.574637

Glioblastoma cells imitate neuronal excitability in humans

Abstract

BackgroundGlioblastomas are renowned for their pronounced intratumoral heterogeneity, characterized by a diverse array of plastic cell types. However, the physiological and transcriptomic features of the cells residing in the invasive leading edge (LE), including both neurons and glioblastoma cells (GBCs), remain unclear, challenging our comprehension of the glioblastoma pathophysiology. MethodsTo elucidate molecular and morphophysiological features of LE cells, we established an experimental workflow enabling the investigation of GBCs and neurons within cancer-infiltrated organotypic tissue specimens from the same patients. With this approach, we characterized the electrophysiological properties of cells in the neocortical tumor LE (LE cells). We further performed single-cell Patch-seq experiments, enabling transcriptomic analysis of electrophysiologically recorded LE cells. ResultsUpon depolarization, 58% of LE cells exhibited aberrant action potentials (aAPs). Electrophysiological assessment showed that a subset of GBCs generated aAPs, with no significant differences in aAP properties compared to LE neurons. Transcriptomic analysis of 144 LE cells revealed four transcriptomic clusters, including two GBC populations and two neuronal populations. LE GBCs exhibited diverse cellular states, including mesenchymal-like, astrocyte-like, neural progenitor-like, and oligodendrocyte-precursor cell-like phenotypes. Notably, LE GBCs exhibiting aAPs displayed reduced mitotic pathway activity and developmental regulatory ion channel CaV1.2. Cell-cell interaction analysis illustrates a higher signaling interaction between aAP LE cells compared to no-aAP LE cells. ConclusionIn summary, we find comparable electrical properties between neurons and a subset of GBCs in the leading edge, suggesting an active electrophysiological role of GBCs in the tumors pathophysiology. Key PointsO_LIHuman organotypic slice cultures enable long-term functional investigation of glioblastoma cells. C_LIO_LIGBCs and neurons in the LE exhibit similar aAPs. C_LIO_LILE GBCs display heterogeneous cellular states, with reduced proliferation signaling in aAP GBCs. C_LI Importance of studyThis study sheds light on the diverse pathophysiological and molecular features of cells in the neocortical infiltration zone of glioblastoma. By utilizing in vitro organotypic human brain slice cultures, a reliable platform for longitudinal observation, we unveiled the dichotomy of the electrical properties of LE cells. More than half of LE cells display aAP, contradicting findings from cultured tumor cells and animal models. Patch-seq analysis confirmed that both GBCs and neurons in the LE generate aAPs with indistinguishable electrical properties. aAP GBCs showed higher cell-cell interactions. We find aAP GBCs to express reduced proliferation signaling compared to no-aAP GBCs, suggesting a non-dividing and potentially more plastic cell state. These findings point to the electrical-active GBCs as an important attribute of the LE, linking the electrophysiological properties with functional implications, and implicate an active role of electrophysiological changes of GBCs in tumor pathophysiology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tong, T., Ozsvar, A., Eschen, J. T., Elbaek, K. J., Cortnum, S. O. S., Sindby, A. K., Kristensen, B. W., Meier, K., Mikic, N., Sorensen, J. C. H., Ting, J. T., Capogna, M., Hou, W.-H., Korshoj, A. R.. 2024-01-08. Glioblastoma cells imitate neuronal excitability in humans. https://doi.org/10.1101/2024.01.08.574637

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression

Both nuclear pore complexes (NPCs) and RNA N6-methyladenosine (m6A) machinery are indispensable for proper cellular function. Although their collaborative roles in the nuclear export of messenger RNAs (mRNAs) have been reported, it remains ambiguous whether and how this collaboration may contribute to cancer progression. Here we identify a functional cooperation between NPCs and m6A signaling that promotes the development of castration-resistant prostate cancer (CRPC). We showed that nuclear export of m6A-modified mRNAs, mediated by the interaction between RNA methyltransferase METTL3 and the nucleoporin NUP93, is functionally coupled to cholesterol biosynthesis. Given that cholesterol-fueled intratumoral androgen production is one of the mechanisms driving CRPC, we demonstrated that overexpression of the wild-type METTL3 or NUP93, but neither the enzymatically dead METTL3 nor the mutant NUP93 that loses METTL3-interacting capability, elevates intracellular levels of androgens, activates AR signaling under castrate condition, and promotes androgen-independent growth of prostate cancer cells both in vitro and in vivo. Importantly, pharmacological inhibition of METTL3 or targeted demethylation on mRNAs encoding key cholesterol biosynthesis enzymes effectively suppressed CRPC malignancy. Together, these findings uncover a therapeutically targetable m6A-METTL3-NUP93 axis that links nuclear mRNA export and metabolic reprogramming to fuel CRPC progression, providing a conceptually new strategy for the treatment of this lethal disease.

cancer biology↗

ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells

Neuroblastoma is the most common extracranial solid tumor of childhood. Its clinical behavior ranges from spontaneous regression to lethal, treatment-refractory disease. Aberrant 2,6-sialylation contributes to aggressive phenotypes in many cancers, but the role of ST6Gal2, a neural-enriched 2,6-sialyltransferase, in neuroblastoma is largely unexplored. Here, we examine the clinical and functional significance of ST6Gal2 in neuroblastoma. In two independent public cohorts (SEQC, n=498; Kocak, n=649), high ST6GAL2 expression was associated with significantly worse overall and event-free survival. In the SEQC cohort, ST6GAL2 expression was higher in high-risk and MYCN-amplified tumors, varied across International Neuroblastoma Staging System stages, and correlated positively with a mesenchymal transcriptional signature (Spearman {rho}=0.181). The mesenchymal correlation was reproduced in the Kocak cohort ({rho}=0.204). Stable shRNA-mediated knockdown of ST6GAL2 in SK-N-AS and SK-N-BE(2) cells reduced proliferation and viability, impaired wound closure, and decreased migration and invasion. In preliminary experiments in SK-N-AS cells, ST6GAL2 knockdown reduced binding of Sambucus nigra agglutinin, consistent with a role for ST6Gal2 in 2,6-sialylation. Together, these findings link ST6Gal2 expression to aggressive clinical and transcriptional features and pro-tumorigenic phenotypes in neuroblastoma and nominate ST6Gal2-mediated sialylation as a candidate pathway for mechanistic study.

cancer biology↗

Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer

The immunomodulatory effects of chemotherapy (chemoimmunomodulation; CIM) are clinically consequential and heterogeneous, yet no systematic framework exists for classifying the immunomodulatory trajectory a tumor follows in response to treatment (CIM trajectory). Here, we present the CIM Induction Classifier (CIMIC), an unsupervised clustering pipeline leveraging delta gene expression across 3,189 CIM-related genes to classify specimens chemoimmunomodulatory trajectory. Applied to two pre- and post-chemotherapy breast cancer (BC) datasets (NKI/SMC, N = 36; NEO, N = 19) and nine epirubicin-perturbed triple-negative BC (TNBC) cell lines, CIMIC identified two divergent CIM trajectories: a functional CIM (Fun-CIM) trajectory, broadly conserved across tumors and cell lines and characterized by induction of inflammatory cell death, antigen presentation, viral mimicry, and adaptive immune activation programs, and a dysfunctional CIM (Dys-CIM) trajectory, characterized by induction of proteostatic and metabolic stress-adaptation programs, reduced immune cell abundances and cytotoxic activity, and enrichment of aggressive BC subtypes. Using survival and longitudinal transcriptomic data in NKI/SMC (N = 20), treatment-induced increases in Fun-CIM-associated genes and ssGSEA scores were associated with reduced recurrence, whereas Dys-CIM-associated genes and scores were associated with increased recurrence. In multivariable analyses within independent chemotherapy-treated BC cohorts (METABRIC, N = 412; SCAN-B, N = 2,462), higher baseline Fun-CIM ssGSEA scores were associated with better outcomes, whereas higher baseline Dys-CIM ssGSEA scores were associated with worse outcomes. These findings establish CIM as a dynamic, trajectory-level process and position CIMIC as a framework for defining CIM trajectories and supporting future efforts to identify predictors, mechanisms, and therapeutic strategies that maximize beneficial CIM.

cancer biology↗